BioCentury | Aug 18, 2017
Finance

Ante Antengene

...its $21 million series A round. Antengene closed the round on Aug. 16. TF Capital, HG Capital...
BioCentury | Aug 18, 2017
Financial News

Antengene raises $21M series A

...in a series A round led by Qiming Venture Partners with participation by TF Capital, HG Capital...
BioCentury | Aug 16, 2017
Financial News

Antengene raises $21M series A

...in a series A round led by Qiming Venture Partners with participation by TF Capital, HG Capital...
BioCentury | Mar 7, 2016
Financial News

Fe3 Medical completes venture financing

...Texas Business: Hematology Date completed: 2016-03-02 Type: Venture financing Raised: $11 million Investors: Jianmin Pharmaceuticals; HG Capital...
Items per page:
1 - 4 of 4
BioCentury | Aug 18, 2017
Finance

Ante Antengene

...its $21 million series A round. Antengene closed the round on Aug. 16. TF Capital, HG Capital...
BioCentury | Aug 18, 2017
Financial News

Antengene raises $21M series A

...in a series A round led by Qiming Venture Partners with participation by TF Capital, HG Capital...
BioCentury | Aug 16, 2017
Financial News

Antengene raises $21M series A

...in a series A round led by Qiming Venture Partners with participation by TF Capital, HG Capital...
BioCentury | Mar 7, 2016
Financial News

Fe3 Medical completes venture financing

...Texas Business: Hematology Date completed: 2016-03-02 Type: Venture financing Raised: $11 million Investors: Jianmin Pharmaceuticals; HG Capital...
Items per page:
1 - 4 of 4